advanced search
Clare Holden
Vice-President, Research & Development, Infusion Care
Convatec

Is this your profile?

About

Clare Holden, Vice-President, Research & Development, Infusion Care. Clare has been with the company since 2019 and has held a variety of leadership roles including in R&D for Continence Care and Ostomy Care.

Contributions

INJECTION
ADVANCING SUBCUTANEOUS INFUSION THERAPY FOR PATIENTS THROUGH INNOVATION AND PARTNERSHIPS
Julien Vandewalle and Clare Holden explain Convatec’s long-term partnerships with pharmaceutical and medical device companies are driving development in chronic care by introducing subcutaneous technologies that support the treatment of conditions such as diabetes and Parkinson’s disease – showcasing Convatec’s Neria™ Guard infusion set.
Top